AAPL310.66-2.00 (-0.64%) ▼|ABBV254.65-0.11 (-0.04%) ▼|ABT95.84+0.21 (+0.22%) ▲|ACN142.14+5.18 (+3.78%) ▲|ADBE221.54+3.47 (+1.59%) ▲|AMAT554.50-38.29 (-6.46%) ▼|AMD516.11-35.94 (-6.51%) ▼|AMGN368.10+1.66 (+0.45%) ▲|AMT165.25+3.14 (+1.94%) ▲|AMZN245.98+1.82 (+0.75%) ▲|AVGO370.78-3.12 (-0.83%) ▼|AXP349.58-6.45 (-1.81%) ▼|BA231.68-2.86 (-1.22%) ▼|BAC59.86-0.04 (-0.07%) ▼|BKNG181.95+0.92 (+0.51%) ▲|BLK1,009.43-1.78 (-0.18%) ▼|BMY57.97+1.27 (+2.24%) ▲|BNY152.91+2.95 (+1.97%) ▲|BRK-B504.00-2.58 (-0.51%) ▼|C140.77-3.09 (-2.15%) ▼|CAT940.12-29.80 (-3.07%) ▼|CL95.03+1.64 (+1.76%) ▲|CMCSA23.41+0.03 (+0.13%) ▲|COF202.89-3.61 (-1.75%) ▼|COP108.44+4.86 (+4.69%) ▲|COST947.50-2.75 (-0.29%) ▼|CRM169.52+3.87 (+2.34%) ▲|CSCO111.79-2.19 (-1.92%) ▼|CVS104.33+2.25 (+2.20%) ▲|CVX174.01+5.91 (+3.52%) ▲|DE603.61-31.63 (-4.98%) ▼|DHR194.19+0.57 (+0.29%) ▲|DIS97.48+0.07 (+0.07%) ▲|DUK128.22+2.25 (+1.79%) ▲|EMR137.91-3.65 (-2.58%) ▼|FDX312.88+2.95 (+0.95%) ▲|GD374.64-2.24 (-0.59%) ▼|GE366.98-11.70 (-3.09%) ▼|GEV1,077.08-74.96 (-6.51%) ▼|GILD136.36+6.75 (+5.21%) ▲|GM76.03-1.82 (-2.34%) ▼|GOOG363.62-1.28 (-0.35%) ▼|GOOGL367.03+0.57 (+0.16%) ▲|GS1,042.98-12.31 (-1.17%) ▼|HD345.21-5.44 (-1.55%) ▼|HON225.05-6.13 (-2.65%) ▼|IBM306.13+6.61 (+2.21%) ▲|INTC110.39-11.81 (-9.66%) ▼|INTU281.17+9.03 (+3.32%) ▲|ISRG427.30-5.53 (-1.28%) ▼|JNJ267.24+7.91 (+3.05%) ▲|JPM339.22+1.50 (+0.44%) ▲|KO84.05+1.09 (+1.31%) ▲|LIN538.23-2.29 (-0.42%) ▼|LLY1,235.56+35.50 (+2.96%) ▲|LMT535.38-2.62 (-0.49%) ▼|LOW220.90-2.88 (-1.29%) ▼|LRCX326.13-24.07 (-6.87%) ▼|MA531.62-1.48 (-0.28%) ▼|MCD282.21+2.71 (+0.97%) ▲|MDLZ60.22+1.05 (+1.77%) ▲|MDT83.83+0.77 (+0.93%) ▲|META615.58+15.29 (+2.55%) ▲|MMM158.01-1.14 (-0.72%) ▼|MO72.96+1.08 (+1.50%) ▲|MRK128.86+2.08 (+1.64%) ▲|MS222.04-0.06 (-0.03%) ▼|MSFT388.84+2.10 (+0.54%) ▲|MU938.38-46.37 (-4.71%) ▼|NEE88.47+1.03 (+1.18%) ▲|NFLX76.18+0.16 (+0.21%) ▲|NKE43.21-0.13 (-0.30%) ▼|NOW110.73+2.80 (+2.59%) ▲|NVDA196.93+1.38 (+0.71%) ▲|ORCL141.60-2.16 (-1.50%) ▼|PEP144.98+1.69 (+1.18%) ▲|PFE24.07+0.35 (+1.48%) ▲|PG152.75+3.44 (+2.30%) ▲|PLTR134.37+1.83 (+1.38%) ▲|PM187.79+3.03 (+1.64%) ▲|QCOM182.97-3.51 (-1.88%) ▼|RTX200.85-0.52 (-0.26%) ▼|SBUX103.61+1.50 (+1.47%) ▲|SCHW101.93+1.31 (+1.30%) ▲|SO97.29+1.30 (+1.35%) ▲|SPG227.19+2.19 (+0.97%) ▲|T21.09+0.51 (+2.48%) ▲|TMO516.62-0.98 (-0.19%) ▼|TMUS184.73+2.94 (+1.62%) ▲|TSLA402.90-16.87 (-4.02%) ▼|TXN293.30-10.20 (-3.36%) ▼|UBER74.33+1.91 (+2.64%) ▲|UNH428.19+10.20 (+2.44%) ▲|UNP283.12+0.53 (+0.19%) ▲|UPS111.96+1.94 (+1.76%) ▲|USB62.89+0.06 (+0.10%) ▲|V352.20-5.05 (-1.41%) ▼|VZ42.59+0.52 (+1.24%) ▲|WFC87.18-0.27 (-0.31%) ▼|WMT111.54+0.89 (+0.80%) ▲|XOM141.69+5.25 (+3.85%) ▲|AAPL310.66-2.00 (-0.64%) ▼|ABBV254.65-0.11 (-0.04%) ▼|ABT95.84+0.21 (+0.22%) ▲|ACN142.14+5.18 (+3.78%) ▲|ADBE221.54+3.47 (+1.59%) ▲|AMAT554.50-38.29 (-6.46%) ▼|AMD516.11-35.94 (-6.51%) ▼|AMGN368.10+1.66 (+0.45%) ▲|AMT165.25+3.14 (+1.94%) ▲|AMZN245.98+1.82 (+0.75%) ▲|AVGO370.78-3.12 (-0.83%) ▼|AXP349.58-6.45 (-1.81%) ▼|BA231.68-2.86 (-1.22%) ▼|BAC59.86-0.04 (-0.07%) ▼|BKNG181.95+0.92 (+0.51%) ▲|BLK1,009.43-1.78 (-0.18%) ▼|BMY57.97+1.27 (+2.24%) ▲|BNY152.91+2.95 (+1.97%) ▲|BRK-B504.00-2.58 (-0.51%) ▼|C140.77-3.09 (-2.15%) ▼|CAT940.12-29.80 (-3.07%) ▼|CL95.03+1.64 (+1.76%) ▲|CMCSA23.41+0.03 (+0.13%) ▲|COF202.89-3.61 (-1.75%) ▼|COP108.44+4.86 (+4.69%) ▲|COST947.50-2.75 (-0.29%) ▼|CRM169.52+3.87 (+2.34%) ▲|CSCO111.79-2.19 (-1.92%) ▼|CVS104.33+2.25 (+2.20%) ▲|CVX174.01+5.91 (+3.52%) ▲|DE603.61-31.63 (-4.98%) ▼|DHR194.19+0.57 (+0.29%) ▲|DIS97.48+0.07 (+0.07%) ▲|DUK128.22+2.25 (+1.79%) ▲|EMR137.91-3.65 (-2.58%) ▼|FDX312.88+2.95 (+0.95%) ▲|GD374.64-2.24 (-0.59%) ▼|GE366.98-11.70 (-3.09%) ▼|GEV1,077.08-74.96 (-6.51%) ▼|GILD136.36+6.75 (+5.21%) ▲|GM76.03-1.82 (-2.34%) ▼|GOOG363.62-1.28 (-0.35%) ▼|GOOGL367.03+0.57 (+0.16%) ▲|GS1,042.98-12.31 (-1.17%) ▼|HD345.21-5.44 (-1.55%) ▼|HON225.05-6.13 (-2.65%) ▼|IBM306.13+6.61 (+2.21%) ▲|INTC110.39-11.81 (-9.66%) ▼|INTU281.17+9.03 (+3.32%) ▲|ISRG427.30-5.53 (-1.28%) ▼|JNJ267.24+7.91 (+3.05%) ▲|JPM339.22+1.50 (+0.44%) ▲|KO84.05+1.09 (+1.31%) ▲|LIN538.23-2.29 (-0.42%) ▼|LLY1,235.56+35.50 (+2.96%) ▲|LMT535.38-2.62 (-0.49%) ▼|LOW220.90-2.88 (-1.29%) ▼|LRCX326.13-24.07 (-6.87%) ▼|MA531.62-1.48 (-0.28%) ▼|MCD282.21+2.71 (+0.97%) ▲|MDLZ60.22+1.05 (+1.77%) ▲|MDT83.83+0.77 (+0.93%) ▲|META615.58+15.29 (+2.55%) ▲|MMM158.01-1.14 (-0.72%) ▼|MO72.96+1.08 (+1.50%) ▲|MRK128.86+2.08 (+1.64%) ▲|MS222.04-0.06 (-0.03%) ▼|MSFT388.84+2.10 (+0.54%) ▲|MU938.38-46.37 (-4.71%) ▼|NEE88.47+1.03 (+1.18%) ▲|NFLX76.18+0.16 (+0.21%) ▲|NKE43.21-0.13 (-0.30%) ▼|NOW110.73+2.80 (+2.59%) ▲|NVDA196.93+1.38 (+0.71%) ▲|ORCL141.60-2.16 (-1.50%) ▼|PEP144.98+1.69 (+1.18%) ▲|PFE24.07+0.35 (+1.48%) ▲|PG152.75+3.44 (+2.30%) ▲|PLTR134.37+1.83 (+1.38%) ▲|PM187.79+3.03 (+1.64%) ▲|QCOM182.97-3.51 (-1.88%) ▼|RTX200.85-0.52 (-0.26%) ▼|SBUX103.61+1.50 (+1.47%) ▲|SCHW101.93+1.31 (+1.30%) ▲|SO97.29+1.30 (+1.35%) ▲|SPG227.19+2.19 (+0.97%) ▲|T21.09+0.51 (+2.48%) ▲|TMO516.62-0.98 (-0.19%) ▼|TMUS184.73+2.94 (+1.62%) ▲|TSLA402.90-16.87 (-4.02%) ▼|TXN293.30-10.20 (-3.36%) ▼|UBER74.33+1.91 (+2.64%) ▲|UNH428.19+10.20 (+2.44%) ▲|UNP283.12+0.53 (+0.19%) ▲|UPS111.96+1.94 (+1.76%) ▲|USB62.89+0.06 (+0.10%) ▲|V352.20-5.05 (-1.41%) ▼|VZ42.59+0.52 (+1.24%) ▲|WFC87.18-0.27 (-0.31%) ▼|WMT111.54+0.89 (+0.80%) ▲|XOM141.69+5.25 (+3.85%) ▲|
21.1 C
New York
Wednesday, July 8, 2026

Tag: plans

newssourceFORcompanyinformationcontent1releasesmarket

Yiren Digital’s Hexiang Insurance Brokers Launched Innovative Insurance Products for Low-Altitude Economy

BEIJING, June 20, 2025 /PRNewswire/ -- Hexiang Insurance Brokers, the insurance brokerage arm of Yiren Digital, has successfully launched specialized insurance products targeting China's...

The Week in Canadian Press Releases: 10 Stories You Need to See

A roundup of the most newsworthy press releases from Cision Distribution this week TORONTO, June 20, 2025 /CNW/ - With thousands of press releases published...

OneFootball Announces Community Presale Of ‘OneFootball Credits’ ($OFC)

OneFootball announces $OFC community presale ahead of Token Generation EventOneFootball Credits will be able to be used OneFootball-wide to redeem unique digital and physical...

Tencent Cloud Empowers Ryde to Elevate In-App Communication in Southeast Asia

HONG KONG, June 20, 2025 /PRNewswire/ -- Tencent Cloud, the cloud business of global leading technology company Tencent, today announced a strategic partnership with Ryde...

So-Young Announces Extension of Plan to Implement ADS Ratio Change

BEIJING, June 20, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers...

Bright Scholar Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

CAMBRIDGE, England and FOSHAN, China, June 20, 2025 /PRNewswire/ -- Bright Scholar Education Holdings Limited ("Bright Scholar" or the "Company") (NYSE: BEDU), a global...

SINGAPORE’S ONLY FESTIVAL, IT’S THE SHIP, UNVEILS EXPLOSIVE FIRST ARTIST ANNOUNCEMENT FOR ASIA’S LARGEST FESTIVAL AT SEA

MAKING THEIR SHIP DEBUT PERFORMANCE: ALOK, TIMMY TRUMPET, NICKY ROMERO TO ROCK THE HIGH SEAS THIS NOVEMBER SINGAPORE, June 20, 2025 /PRNewswire/ -- IT'S THE SHIP,...

NurExone Advances U.S. Growth Strategy with Acceptance into Prestigious ARMI HealthTech Hub Accelerator and Provides Corporate Update

TORONTO and HAIFA, Israel, June 20, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biotech company developing exosome-based therapies for central nervous system injuries, announced today that it has been accepted into the HealthTech Hub (“HTH”) Accelerator Program. Based in Boston, Massachusetts, home to more than 1,000 biotech companies1, HTH is operated by the Advanced Regenerative Manufacturing Institute (“ARMI”) and its BioFabUSA initiative.

Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)

Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use compared to placebo in adults with BP

Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid

European Companies: Analyzing Tariff Impacts on Operational and Financial Performance

The current landscape for European businesses is marked by significant challenges stemming from the U.S. administration's tariff policies under President Trump. These measures have...

Chinese Firms Eye Brazil—Because Who Needs Stability Anyway?

Amid the relentless cacophony of trade wars and collapsing markets, Chinese consumer brands, with a touch of desperation and a sprinkle of audacity, have...

Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025

MELBOURNE, Australia and INDIANAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces five abstract presentations and two satellite symposia featuring its developmental theranostic programs and commercial products at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025 Annual Meeting being held in New Orleans, Louisiana (U.S.) from June 21 – 24.

Shipsy to Drive Rapid Expansion in Australia, Establishes Regional Headquarters in Sydney to Support Growing Client Base

SYDNEY, June 20, 2025 /PRNewswire/ -- Shipsy, a Gartner-recognized global leader in AI-powered SaaS-based logistics management platform provider, recently announced its plans to aggressively...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPlans

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers